Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
When my first detectable PSA test came in five years ago, I was even more terrified and panicked than when I was initially diagnosed.
Our new Online Women’s Support Group draws on our experience of launching and running our Online Men’s Support Group.
An antibody-drug conjugate could be a step toward selective treatment for neuroendocrine prostate cancer.
While disease progression was higher in Black men, their rates of metastasis and mortality were similar to those of white men.
An unexpected conversation about my PSA test results, and my long overdue vacation trip to Utah’s national parks.
The NBC anchor revealed his early-stage yet aggressive cancer diagnosis on air to encourage men, especially Black men, to get screened.
The blood test identifies biomarkers that could make patients eligible for targeted therapies.
New study looks at long-term impacts in people with prostate, bladder, colorectal and lung cancers
Researchers are developing a new class of drugs called radiopharmaceuticals, which deliver radiation therapy directly to cancer cells.
Study finds bone health testing for patients with prostate cancer undergoing ADT therapy are not meeting guideline recommendations.
A new podcast explores what it’s really like to have this common disease.
Black patients should also benefit from recently approved PARP Inhibitor therapies “if applied equitably,” study finds
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
The treatment method was found to be safe and effective in comparison with surgery or radiation.
The Institute for Prostate Cancer Research has launched a series of exercise videos for people with prostate cancer.
As we negotiate this pandemic, do your days seem to blend together and you lose track of time?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.